An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of Trichuris trichiura and other STH infections. ALIVE trial protocol

Journal: Gates Open Res

Volume: 

Issue: 

Year of Publication: 2022

Affiliated Institutions: 

Statistics

Citations :  2
Authors :  0

Identifiers

Doi : 10.12688/gatesopenres.13615.1
SSN : 

Study Population

Male,Female

Mesh Terms

Other Terms

Study Design

Study Approach

Country of Study

Kenya

Publication Country